Psychedelic drug discovery & optimization company CaaMTech Inc. and the psychedelics discovery, development & educational organization Alexander Shulgin Research Institute Inc. (ASRI) have recently signed an agreement to carry out structural and chemical analyses to further develop novel compounds designed and synthesized by the late Dr. Alexander Shulgin.
Known as “the Godfather of psychedelics,” Dr. Shulgin was a biochemist and pharmacologist known for his documented synthesis, which included personal testing of many unreported psychoactive compounds.
